GLENMEDE TRUST CO NA - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$5,000
-16.7%
4,200
+0.8%
0.00%
Q2 2020$6,0000.0%4,1660.0%0.00%
Q1 2020$6,0000.0%4,1660.0%0.00%
Q4 2019$6,000
-57.1%
4,1660.0%0.00%
Q3 2019$14,000
-6.7%
4,1660.0%0.00%
Q2 2019$15,000
-65.1%
4,1660.0%0.00%
Q1 2019$43,0000.0%4,1660.0%0.00%
Q4 2018$43,000
-12.2%
4,1660.0%0.00%
Q2 2018$49,000
-10.9%
4,1660.0%0.00%
Q1 2018$55,0000.0%4,1660.0%0.00%
Q4 2017$55,0004,1660.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders